OpenVSafe by OpenVAERS
Search V-safe

XXB-23088-18985

2 vaccinations 4 coded responses 14 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
011 / MA
Registered
2021-04-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-09
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-30
    Registered in v-safe
  3. 2021-04-30
    Dose 2 — Pfizer-BioNTech
  4. 2021-04-30
    Health check-in — 0 day, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-05-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Asthenia — Feeling: Good · Site: Pain, Swelling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  6. 2021-05-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Flushing — Feeling: Good · Site: Pain, Redness, Swelling · Headache
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  7. 2021-05-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-05-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-05-07
    Health check-in — 7 day, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-05-14
    Health check-in — 14 day, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-05-24
    Health check-in — 21 day, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-05-30
    Health check-in — 28 day, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-06-04
    Health check-in — 35 day, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-06-11
    Health check-in — 42 day, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-07-30
    Survey response — 3 month, dose 2
    MedDRA: Nasopharyngitis, Oropharyngeal pain, Sinus congestion — Feeling: Good · Be unable to work or attend school
    MedDRA releases: 2021-09,2024-11 · check-in answers available
  16. 2021-10-29
    Health check-in — 6 month, dose 2
    Feeling: Good
    Adult check-in
  17. 2022-04-30
    Survey response — 12 month, dose 2
    MedDRA: COVID-19, Interchange of vaccine products, Sleep disorder — Feeling: Good · Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available

Vaccinations

DoseDateManufacturerCo-administered
12021-04-09Pfizer-BioNTech
22021-04-30Pfizer-BioNTech

Free text

Release 8

Systemic reaction (other): Very slight decrease in strength during my regular saturday strength weight today

Systemic reaction (other): While not over the threshold to be considered a fever, my core temp was evevated 1° above my normal 97.6 and I did feel slightly flushed

Release 9

Symptoms: Caught a cold at a wedding, sore throat 2 days, migrated to sinus congestion for 4 more days, no chest involvement or cough, no feverVaccinated family and vaccinated extended family all had same sx set and progression

Release 11

Symptoms: Covid 1/3/22 (contracted from a vaccine only small party of 12 ppl 1/1) I received 2 Pfizer and 1 Moderna booster. I do have persistent, but mild to moderate sleep disturbance since covid. Otherwise my observable Sx seem to have resolved

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDInterchange of vaccine products · · ✓
SDNasopharyngitis ✓ · ✓
SDOropharyngeal pain ✓ · ✓
SDSinus congestion ✓ · ✓
SDSleep disorder · · ✓
SROAsthenia ✓ ✓ ✓
SROFlushing ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release